29/05/201321/10/2023 HELIX BIOPHARMA CORP. INITIATES ENROLLMENT FOR FOURTH COHORT IN POLISH PHASE I/II CLINICAL STUDY OF ITS LUNG CANCER DRUG CANDIDATE L-DOS47 admin 0 Comments